跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,698 条关于
“Mizuho Financial Group”
全部
31,698
临床试验
18,375
药物
557
机构
546
资讯
12,220
3个月前
Bharat Innovates 2026 Day Two: Over 40 Startups Secure Investor Commitments, $254.5 Million in Funding Announced
去年
Mizuho Securities Maintains Hold Rating on Neurocrine as Osavampator Development Faces Timeline Uncertainties
2年前
Apellis Awaits EU Decision on Pegcetacoplan (Syfovre) Amidst Positive Phase 3 Kidney Data
去年
Apellis Faces Setback as EMA Rejects Pegcetacoplan, Mizuho Lowers Price Target
去年
Pharming Group Appoints Kenneth Lynard as Chief Financial Officer to Strengthen Rare Disease Growth Strategy
3个月前
Mizuho Strategist Reframes Healthcare as a Value Sector Amid Pharma Underperformance, Highlights Merck's Keytruda Dominance
2年前
Pharmacosmos Group Acquires G1 Therapeutics for $405 Million to Expand COSELA Access for Cancer Patients
去年
Stevanato Group Secures €200 Million Financing to Expand Biologics Manufacturing Capacity
去年
Psyence Group Expands Psilocybin Clinical Trials for Adjustment Disorder in Palliative Care
2年前
EMA's Advisory Group to Review Lecanemab for Alzheimer's Treatment
第 1 页,共 1222 页
上一页
下一页